9-Me-BC is a research compound. It is not approved by the FDA or any regulatory body for human use. This article is for educational and informational purposes only. Nothing here constitutes medical advice. Consult a qualified physician before considering any peptide use.
9-Me-BC (9-Methyl-β-carboline) is researched primarily for dopamine elevation, neuroprotection, improved spatial learning, enhanced dendritic complexity, cognitive enhancement, potential anti-Parkinsonian activity. Dual mechanism of MAO inhibition plus neurotrophic factor stimulation makes it unique for dopaminergic restoration — one of the few compounds that both preserves existing dopamine AND grows new dopaminergic neurons. It belongs to the Monoamine oxidase inhibitor, neuroprotective agent category of compounds.
What Is 9-Me-BC?
9-Me-BC (9-Methyl-β-carboline) is a Monoamine oxidase inhibitor, neuroprotective agent. Synthetic indole alkaloid derivative targeting dopaminergic neuroprotection.
Dual mechanism of MAO inhibition plus neurotrophic factor stimulation makes it unique for dopaminergic restoration — one of the few compounds that both preserves existing dopamine AND grows new dopaminergic neurons. It has attracted significant research interest for its potential effects on dopamine elevation, neuroprotection, improved spatial learning, enhanced dendritic complexity, cognitive enhancement, potential anti-Parkinsonian activity.
How Does 9-Me-BC Produce These Benefits?
Inhibits MAO-A (IC50: 1 μM) and MAO-B (IC50: 15.5 μM), preventing dopamine degradation and extending its activity. Simultaneously stimulates neurotrophic factor gene expression including BDNF, GDNF, and ARTN through the PI3K/Akt signaling pathway, promoting both dopaminergic neuron survival and new dendritic growth.
This multi-pathway activity is why 9-Me-BC shows potential across several different applications rather than being limited to a single use case.
Can 9-Me-BC Help With Dopamine Elevation?
Research suggests 9-Me-BC may support dopamine elevation through its monoamine oxidase inhibitor, neuroprotective agent activity. Reversed dopamine depletion in MPTP neurotoxin models, restoring dopaminergic neurons to normal levels. Improved spatial learning and elevated hippocampal dopamine in 10-day mouse studies. No human clinical trials — preclinical evidence only.
Protocols targeting dopamine elevation typically use 15-30 mg daily administered once daily for 7-10 days (short cycles recommended due to MAO inhibition).
Can 9-Me-BC Help With Neuroprotection?
Research suggests 9-Me-BC may support neuroprotection through its monoamine oxidase inhibitor, neuroprotective agent activity. Reversed dopamine depletion in MPTP neurotoxin models, restoring dopaminergic neurons to normal levels. Improved spatial learning and elevated hippocampal dopamine in 10-day mouse studies. No human clinical trials — preclinical evidence only.
Protocols targeting neuroprotection typically use 15-30 mg daily administered once daily for 7-10 days (short cycles recommended due to MAO inhibition).
Can 9-Me-BC Help With Improved Spatial Learning?
Research suggests 9-Me-BC may support improved spatial learning through its monoamine oxidase inhibitor, neuroprotective agent activity. Reversed dopamine depletion in MPTP neurotoxin models, restoring dopaminergic neurons to normal levels. Improved spatial learning and elevated hippocampal dopamine in 10-day mouse studies. No human clinical trials — preclinical evidence only.
Protocols targeting improved spatial learning typically use 15-30 mg daily administered once daily for 7-10 days (short cycles recommended due to MAO inhibition).
Can 9-Me-BC Help With Enhanced Dendritic Complexity?
Research suggests 9-Me-BC may support enhanced dendritic complexity through its monoamine oxidase inhibitor, neuroprotective agent activity. Reversed dopamine depletion in MPTP neurotoxin models, restoring dopaminergic neurons to normal levels. Improved spatial learning and elevated hippocampal dopamine in 10-day mouse studies. No human clinical trials — preclinical evidence only.
Protocols targeting enhanced dendritic complexity typically use 15-30 mg daily administered once daily for 7-10 days (short cycles recommended due to MAO inhibition).
Can 9-Me-BC Help With Cognitive Enhancement?
Research suggests 9-Me-BC may support cognitive enhancement through its monoamine oxidase inhibitor, neuroprotective agent activity. Reversed dopamine depletion in MPTP neurotoxin models, restoring dopaminergic neurons to normal levels. Improved spatial learning and elevated hippocampal dopamine in 10-day mouse studies. No human clinical trials — preclinical evidence only.
Protocols targeting cognitive enhancement typically use 15-30 mg daily administered once daily for 7-10 days (short cycles recommended due to MAO inhibition).
Can Stacking Enhance 9-Me-BC Benefits?
Complements other neuroprotective agents like Dihexa and Semax for comprehensive cognitive enhancement. Use caution stacking with serotonergic compounds due to MAO inhibition.
See our 9-Me-BC stacking guide for detailed combination protocols.
What Is the Bottom Line on 9-Me-BC Benefits?
9-Me-BC is researched for dopamine elevation, neuroprotection, improved spatial learning, enhanced dendritic complexity, cognitive enhancement, potential anti-Parkinsonian activity. The evidence base includes: Reversed dopamine depletion in MPTP neurotoxin models, restoring dopaminergic neurons to normal levels. Improved spatial learning and elevated hippocampal dopamine in 10-day mouse studies. No human clinical trials — preclinical evidence only.
9-Me-BC is not fda-approved. research compound only. unregulated. Source from reputable vendors with third-party testing for reliable results.
Complete Guide
9-Me-BC : Benefits, Dosage, Side Effects & Research
Related Reading
- 9-Me-BC Dosage Guide
- 9-Me-BC Side Effects
- 9-Me-BC Stacking Guide
- 9-Me-BC Cycle Guide
- 9-Me-BC Research
- Dihexa Complete Guide
Calculate Your 9-Me-BC Dose
Use our free peptide dosing calculator to get exact reconstitution math and syringe units for 9-Me-BC.
Open Calculator →Research-Grade Sourcing
If you're going to research 9-Me-BC, source matters. These are the suppliers WolveStack has vetted for purity and third-party testing.
Frequently Asked Questions
What is 9-Me-BC?
9-Me-BC (9-Methyl-β-carboline) is a Monoamine oxidase inhibitor, neuroprotective agent. Synthetic indole alkaloid derivative targeting dopaminergic neuroprotection. It is researched for dopamine elevation, neuroprotection, improved spatial learning, enhanced dendritic complexity, cognitive enhancement, potential anti-Parkinsonian activity.
What is the recommended 9-Me-BC dosage?
Common dosages: 15-30 mg daily administered once daily via oral or subcutaneous. Cycle length: 7-10 days (short cycles recommended due to MAO inhibition). Half-life: not established. Use our peptide calculator for exact reconstitution math.
What are the side effects of 9-Me-BC?
Dose-dependent toxicity at high concentrations in cell cultures. No human safety data available. As an MAO inhibitor, carries risk of tyramine interactions (avoid aged cheese, cured meats, fermented foods). Photosensitivity reported — avoid UV exposure during use.
Is 9-Me-BC safe?
9-Me-BC has shown a preliminary safety profile in research. Not FDA-approved. Research compound only. Unregulated. All research should follow appropriate safety protocols.